申请人:The Board of Regents of the University of Texas S
公开号:US20130150442A1
公开(公告)日:2013-06-13
The present invention includes bis- and tris-benzamide compounds that block AR signaling and have activity against prostate cancer. Uses for these compounds, and pharmaceutical compositions containing the same, also are provided.